HES5 and plasma cell leukemia: Our first observation was obtained by GEP analysis and indicated that the trend of Notch signaling activation (evaluated by HES5 expression levels) reflected the acquisition of a highly malignant phenotype, since it occurred in high-risk cytogenetics MM and PCL patients who displayed the highest activation levels.